Emerging oral atypical antipsychotics to compete in increasingly crowded … - News-Medical.net
The Pharmacor 2010 findings from the topic entitled Schizophrenia reveals that emerging oral atypical antipsychotics such as Merck's Saphris/Sycrest
Источник: